CU Medical Systems, Inc.
Financials
Valuation Metrics
CU Medical Systems, Inc.'s Market Cap is ₩283B. At end of 2025 it was ₩333B. Ranked #2131 of 2,421 in KR market (top 88%), #1374 of 1,640 on KOSDAQ (top 84%), #87 of 96 in Health Care Equipment & Services (top 91%) by Market Cap.
Investment Metrics(as of 2026-09-18)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 28.31B KRW | KR#2,131/2,421 Sec#87/96 |
| Revenue | 63.43B KRW | KR#1,667/2,421 Sec#49/96 |
| Net Income | 9.13B KRW | KR#1,003/2,421 Sec#27/96 |
| Total Assets | 139.92B KRW | KR#1,558/2,421 Sec#46/96 |
| Net Assets | 79.86B KRW | KR#1,587/2,421 Sec#46/96 |
| Employees | 120 | KR#1,506/2,421 Sec#52/96 |
| Value | ||
| P/E | 3.10x | KR#163/2,421 Sec#2/96 |
| P/B | 0.35x | KR#460/2,421 Sec#6/96 |
| P/S | 0.45x | KR#839/2,421 Sec#4/96 |
| EV/EBITDA | 3.00x | KR#84/2,421 Sec#3/96 |
| FCF Yield | 32.31% | KR#164/2,421 Sec#3/96 |
| Profitability | ||
| ROE | 11.43% | KR#514/2,421 Sec#22/96 |
| ROA | 6.53% | KR#568/2,421 Sec#30/96 |
| Op. Margin | 23.42% | KR#113/2,421 Sec#8/96 |
| Revenue Growth | 55.49% | KR#175/2,421 Sec#11/96 |
| Financial Health | ||
| Debt Ratio | 75.20% | KR#1,282/2,421 Sec#70/96 |
| Total Debt | 47.21B KRW | KR#1,028/2,421 Sec#25/96 |
| FCF | 9.15B KRW | KR#733/2,421 Sec#18/96 |
| Cash | 30.92B KRW | KR#993/2,421 Sec#25/96 |
| Current Ratio | 1.17x | KR#1,529/2,421 Sec#75/96 |
| Net Debt/EBITDA | 1.10x | KR#745/2,421 Sec#32/96 |
| Performance | ||
| 1Y Return | -25.87% | KR#1,426/2,421 Sec#34/96 |
| 1M Return | 6.38% | KR#665/2,421 Sec#17/96 |
| From 52W High | -29.46% | KR#512/2,421 Sec#18/96 |
| 1Y MDD | -47.05% | KR#859/2,421 Sec#29/96 |
| Trading | ||
| Volume | 15,056 shares | KR#1,731/2,421 Sec#67/96 |
| Trading Value | 35.0M KRW | KR#1,962/2,421 Sec#78/96 |
| Foreign Own. | 0.00% | KR—/2,421 Sec—/96 |
| Per Share | ||
| EPS | 753 KRW | KR#834/2,421 Sec#19/96 |
| BPS | 6,587 KRW | KR#1,289/2,421 Sec#30/96 |
Company Info
CU Medical, established in 2001 and headquartered in Wonju-si, Gangwon-do, listed on KOSDAQ in 2011. The company specializes in developing, manufacturing, and selling medical devices, notably being the first in Asia to develop and market defibrillators. It offers a comprehensive product range, from general-use to hospital-specific devices, and is launching new Automated External Defibrillator (AED) products with world-first IP66 and IP68 ratings. With local subsidiaries in Germany and Japan, CU Medical implements tailored sales strategies for global markets.